196 related articles for article (PubMed ID: 18032477)
1. Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events.
Mumy KL; Chen X; Kelly CP; McCormick BA
Am J Physiol Gastrointest Liver Physiol; 2008 Mar; 294(3):G599-609. PubMed ID: 18032477
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells.
Dahan S; Dalmasso G; Imbert V; Peyron JF; Rampal P; Czerucka D
Infect Immun; 2003 Feb; 71(2):766-73. PubMed ID: 12540556
[TBL] [Abstract][Full Text] [Related]
3. Human Intestinal Enteroids as a Model System of
Koestler BJ; Ward CM; Fisher CR; Rajan A; Maresso AW; Payne SM
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642906
[TBL] [Abstract][Full Text] [Related]
4. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice.
Rodrigues AC; Nardi RM; Bambirra EA; Vieira EC; Nicoli JR
J Appl Bacteriol; 1996 Sep; 81(3):251-6. PubMed ID: 8810053
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells.
Czerucka D; Dahan S; Mograbi B; Rossi B; Rampal P
Infect Immun; 2000 Oct; 68(10):5998-6004. PubMed ID: 10992512
[TBL] [Abstract][Full Text] [Related]
6. Effect of wild-type Shigella species and attenuated Shigella vaccine candidates on small intestinal barrier function, antigen trafficking, and cytokine release.
Fiorentino M; Levine MM; Sztein MB; Fasano A
PLoS One; 2014; 9(1):e85211. PubMed ID: 24416363
[TBL] [Abstract][Full Text] [Related]
7. IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis.
Singer M; Sansonetti PJ
J Immunol; 2004 Sep; 173(6):4197-206. PubMed ID: 15356171
[TBL] [Abstract][Full Text] [Related]
8. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence.
Zurawski DV; Mitsuhata C; Mumy KL; McCormick BA; Maurelli AT
Infect Immun; 2006 Oct; 74(10):5964-76. PubMed ID: 16988276
[TBL] [Abstract][Full Text] [Related]
9. Kefir-isolated bacteria and yeasts inhibit Shigella flexneri invasion and modulate pro-inflammatory response on intestinal epithelial cells.
Bolla PA; Abraham AG; Pérez PF; de Los Angeles Serradell M
Benef Microbes; 2016 Feb; 7(1):103-110. PubMed ID: 26503738
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Shigella flexneri-induced transepithelial migration of polymorphonuclear leucocytes by cadaverine.
McCormick BA; Fernandez MI; Siber AM; Maurelli AT
Cell Microbiol; 1999 Sep; 1(2):143-55. PubMed ID: 11207548
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of bacillary dysentery: lessons learnt from infant rabbits.
Yum LK; Agaisse H
Gut Microbes; 2020 May; 11(3):597-602. PubMed ID: 31570038
[TBL] [Abstract][Full Text] [Related]
12. Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
Dalmasso G; Cottrez F; Imbert V; Lagadec P; Peyron JF; Rampal P; Czerucka D; Groux H; Foussat A; Brun V
Gastroenterology; 2006 Dec; 131(6):1812-25. PubMed ID: 17087945
[TBL] [Abstract][Full Text] [Related]
13. A murine model of diarrhea, growth impairment and metabolic disturbances with
Q S Medeiros PH; Ledwaba SE; Bolick DT; Giallourou N; Yum LK; Costa DVS; Oriá RB; Barry EM; Swann JR; Lima AÂM; Agaisse H; Guerrant RL
Gut Microbes; 2019; 10(5):615-630. PubMed ID: 30712505
[No Abstract] [Full Text] [Related]
14. Shigella flexneri infection in Caenorhabditis elegans: cytopathological examination and identification of host responses.
George DT; Behm CA; Hall DH; Mathesius U; Rug M; Nguyen KC; Verma NK
PLoS One; 2014; 9(9):e106085. PubMed ID: 25187942
[TBL] [Abstract][Full Text] [Related]
15. Rupture of the intestinal epithelial barrier and mucosal invasion by Shigella flexneri.
Sansonetti PJ; Tran Van Nhieu G; Egile C
Clin Infect Dis; 1999 Mar; 28(3):466-75. PubMed ID: 10194063
[TBL] [Abstract][Full Text] [Related]
16. Development of an improved animal model of shigellosis in the adult rabbit by colonic infection with Shigella flexneri 2a.
Rabbani GH; Albert MJ; Rahman H; Islam M; Mahalanabis D; Kabir I; Alam K; Ansaruzzaman M
Infect Immun; 1995 Nov; 63(11):4350-7. PubMed ID: 7591070
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon.
Coron E; Flamant M; Aubert P; Wedel T; Pedron T; Letessier E; Galmiche JP; Sansonetti PJ; Neunlist M
PLoS One; 2009; 4(3):e4713. PubMed ID: 19274103
[TBL] [Abstract][Full Text] [Related]
18. [Calpain activation by Shigella flexneri regulates key steps in the life and death of bacterium's epithelial niche].
Bergounioux J; Arbibe L
Med Sci (Paris); 2012 Dec; 28(12):1029-31. PubMed ID: 23290392
[No Abstract] [Full Text] [Related]
19. Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression.
Sougioultzis S; Simeonidis S; Bhaskar KR; Chen X; Anton PM; Keates S; Pothoulakis C; Kelly CP
Biochem Biophys Res Commun; 2006 Apr; 343(1):69-76. PubMed ID: 16529714
[TBL] [Abstract][Full Text] [Related]
20. Requirement of the Shigella flexneri virulence plasmid in the ability to induce trafficking of neutrophils across polarized monolayers of the intestinal epithelium.
McCormick BA; Siber AM; Maurelli AT
Infect Immun; 1998 Sep; 66(9):4237-43. PubMed ID: 9712773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
